Brought to you by 
Glaxo, SmithKline merge
06 Sep 2001
Executive Summary
SmithKline Beecham and Glaxo Wellcome are merging, creating Glaxo SmithKline, a company with annual sales of $25bn, a market cap of $189bn, and 40k employees. Glaxo shareholders will own 58.75% of the new company. The transaction is expected to close this summer, and values SB at $78bn.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Glaxo, SmithKline merge
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice